Clinical Performance of BioCLIA Ro60

Withdrawn before enrolling

Conditions studied: Systemic Lupus Erythematosus, Sjogren's Syndrome

In brief

The study is to evaluate the clinical performance of BioCLIA Ro60 for measuring the autoantibody in autoimmune disease patients.

Key facts

Study ID

NCT03204448

Run by

HOB Biotech Group

People needed

0

Starts

2017-05-08

Expected to finish

2020-04-16

Last updated by the study team

2020-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with relevant diseases, including Systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS)
• Or diagnosed with other control diseases, including Rheumatoid arthritis (RA), Infectious diseases and others

You may not qualify if…

• Treatment with medicine that submerge the autoantibody concentration to non-detectable range
• Co-diagnosed with multiple relevant diseases (e.g., SLE / SS) and/or control diseases
• Hemolyzed sample.

Where it is running

• CRM Biotech — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.